New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2014
08:47 EDTCMCSA, GSK, TSLA, MSFT, SNE, F, KW, NFX, APC, MUR, WFC, MU, CSCO, CHTR, TWC, ARNAOn the Fly: Periodicals Wrap
WSJ: Comcast's (CMCSA) Obama relationships to be tested in Time Warner Cable (TWC) deal...Charter (CHTR) likely to seek other acquisitions...Cisco's (CSCO) memory issue may be tied to Micron (MU)...REUTERS: Wells Fargo (WFC) moves back into the subprime home market...Murphy Oil (MUR) may sell about $3B of Asian assets...Brightoil interested in Anadarko (APC), Newfield (NFX) China operations...Kennedy Wilson (KW) looks to raise $1.25B from European property unit...BLOOMBERG: Ford (F) sales dominated by small SUVs...Sony (SNE) PlayStation beats Microsoft (MSFT) Xbox One sales...Tesla (TSLA) looking into cause of Toronto Model S fire...OTHER NEWS: GlaxoSmithKline (GSK) interested in Arena (ARNA), Daily Mail reports.
News For CMCSA;TWC;CHTR;CSCO;MU;WFC;MUR;APC;NFX;KW;F;SNE;MSFT;TSLA;GSK;ARNA From The Last 14 Days
Check below for free stories on CMCSA;TWC;CHTR;CSCO;MU;WFC;MUR;APC;NFX;KW;F;SNE;MSFT;TSLA;GSK;ARNA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
August 11, 2014
09:06 EDTTSLAOn The Fly: Pre-market Movers
HIGHER: PharmAthene (PIP), up 55% after announcing that a Delaware court awarded the company lump sum expectation damages for the value of its lost profits for SIGA Technologies' (SIGA) smallpox antiviral, Tecovirimat... MannKind (MNKD), up 19% after entering exclusive licensing agreement for development and commercialization of Afrezza inhaled insulin with Sanofi (SNY)... Kinder Morgan (KMI), up 19% after announcing it will acquire all of the outstanding equity securities of Kinder Morgan Energy Partners (KMP), Kinder Morgan Management (KMR) and El Paso Pipeline Partners (EPB)... Tesla (TSLA), up 2.7% following upgrade at Deutsche Bank... Achillion (ACHN), up 6% following upgrades at Wells Fargo and at Piper Jaffray... PepsiCo (PEP), up 0.9% following upgrade at UBS. LOWER: Dean Foods (DF), down 8.6% after reporting Q2 losses that were steeper than expected, saying balance of year "appears rocky," which makes it difficult to provide guidance beyond the immediate quarter... Priceline (PCLN), down 0.7% after reporting Q2 revenue that missed expectations, guiding Q3 EPS below consensus... SIGA Technologies, down 31% after ruling in suit with PharmAthene... 2U (TWOU), down 4.3% after downgraded at Goldman.
08:47 EDTGSKGlaxo to conduct Ebola vaccine trials later this year, Guardian says
Subscribe for More Information
07:50 EDTMUMicron pullback creates buying opportunity, says Jefferies
Jefferies attributes the recent pullback in shares of Micron to Samsung's DRAM bit growth commentary and Micron's guidance for higher capital expenditures in FY15. Jefferies expects favorable DRAM supply/demand balance to continue through 2015 and thinks Micron will continue to see near-term pricing power. The firm recommends buying the stock at current levels and keeps a Buy rating on Micron with a $38 price target.
06:38 EDTTSLATesla upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded its rating on Tesla (TSLA) shares to Buy saying it expects the electric car maker to be much more profitable than previously thought following comments on the company's Q2 earnings call. Deutsche now thinks Tesla can produce 500,000 units of annual production by late this decade. It raised its price target for the stock to $310 from $220. Shares of Tesla closed Friday down $2.46 to $248.13.
06:35 EDTMSFTMicrosoft Devices unveils low-cost Nokia 130 phone
Subscribe for More Information
06:01 EDTAPCStocks with implied volatility movement; S APC
Subscribe for More Information
05:55 EDTCSCOCisco expected to report solid Q4 results at Wells Fargo
Subscribe for More Information
August 8, 2014
16:00 EDTTSLAOptions Update; August 8, 2014
Subscribe for More Information
12:49 EDTSNEChina chosen as first market for Sony 4K curved TV's, Nikkei reports
Subscribe for More Information
11:13 EDTFFord China reports July sales up 25% to 90,775 vehicles sold
Subscribe for More Information
10:21 EDTAPCAnadarko calls active on renewed takeover chatter
Subscribe for More Information
10:18 EDTAPCRumor: Anadarko moves up on renewed takeover chatter
Subscribe for More Information
09:37 EDTTSLAActive equity options trading on open
Subscribe for More Information
09:10 EDTMUMicron shares should be bought on weakness, says Sterne Agee
Subscribe for More Information
09:03 EDTGSKGlaxoSmithKline weakness creates buying opportunity, says Argus
Subscribe for More Information
08:42 EDTMSFTMicrosoft has made strong progress in cloud, says Pacific Crest
Subscribe for More Information
08:32 EDTMSFTVMware, others could benefit from increased cloud adoption, says Pacific Crest
Subscribe for More Information
08:31 EDTCSCOMorgan Stanley expects Cisco to report good results, conservative outlook
Morgan Stanley expects Cisco to report results of 54c/$12.26B vs. consensus of 53c/$12.14B and said checks indicate the enterprise market is improving. The firm expects Cisco's outlook to be conservative and said concerns over rapid software-defined networking adoption and margin impact are overblown. Shares are Overweight rated with a $30 price target.
07:18 EDTWFCRegulators direct banks to steer mortgage aid to hard-hit areas, FT says
Subscribe for More Information
06:18 EDTGSKRoyal Bank of Scotland's Hampton leads race to become new GSK chair, FT reports
Royal Bank of Scotland (RBS) Chairman Philip Hampton is the frontrunner to succeed Christopher Gent as chairman of GlaxoSmithKline (GSK), the Financial Times reports, citing sources. Gent will step down from his role at GSK next year. Hampton is not expected to step down from RBS until after May's general election, the sources say. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use